GenSight Biologics Announces Closing of Fundraising Worth Nearly EUR 2 Million

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN AND SOUTH AFRICA ...
ophthalmologyadvisor

Idebenone Under Review for Leber Hereditary Optic Neuropathy

A Prescription Drug User Fee Act target date of February 28, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...
modernretina

Idebenone accepted by FDA for priority review for Leber Hereditary Optic Neuropathy

The submission was based on the safety and efficacy data from the phase 3 (RHODOS) and phase 4 (LEROS) studies. The US Food and Drug Administration (FDA) has granted Priority Review to Chiesi Global ...
abc27

Idebenone Accepted by FDA for Priority Review for Leber Hereditary Optic Neuropathy (LHON)

FDA grants Priority Review to idebenone for Leber Hereditary Optic Neuropathy (LHON), a disease for which there are no existing approved treatments in the U.S.; action date of February 28, 2026 PARMA, ...
ABC57

ABC57 Health Alert: Sudden blindness, dealing with this rare hereditary disease

SOUTH BEND, Ind. -- Imagine your vision starts to blur, partially at first, maybe even in just one eye, but over time it starts to get worse. And when you talk to your doctor about it, you may ...
Hosted on MSN

Bodybuilder Tries Training Blind for 24 Hours!

What happens when a bodybuilder loses his vision but refuses to give up? Meet Justin Holland, a competitive bodybuilder who went blind due to Leber’s Hereditary Optic Neuropathy. Instead of letting it ...
Frontiers

Late-onset Leber’s hereditary optic neuropathy and antiandrogens for prostate cancer: is there a causative link?

Introduction: Leber’s hereditary optic neuropathy (LHON) is a maternally inherited condition due to mitochondrial DNA (mtDNA) mutations usually affecting young men within their thirties, while women ...